FDA Approves New Advancements for Levothyroxine Sodium in Hypothyroidism Treatment
The FDA has approved significant label changes for Tirosint-SOL, an oral solution for hypothyroidism, allowing its use with PPIs and administration before breakfast, setting it apart from other treatments.
